Positron Emission Tomography Imaging Evaluation of a Novel <SUP>18</SUP>F-Labeled Sigma-1 Receptor Radioligand in Cynomolgus Monkeys

Hongmei Jia,Zhengxin Cai,Daniel Holden,Yingfang He,Shu-fei Lin,Songye Li,Evan Baum,Anupama Shirali,Michael Kapinos,Hong Gao,Jim Ropchan,Yiyun Huang
DOI: https://doi.org/10.1021/acschemneuro.0c00171
2020-01-01
ACS Chemical Neuroscience
Abstract:We report a convenient radiosynthesis and the first positron emission tomography (PET) imaging evaluation of [F-18]FBFP as a potent sigma-1 (sigma(1)) receptor radioligand with advantageous characteristics. [F-18]FBFP was synthesized in one step from an iodonium ylide precursor. In cynomolgus monkeys, [F-18]FBFP displayed high brain uptake and suitable tissue kinetics for quantitative analysis. It exhibited heterogeneous distribution with higher regional volume of distribution (V-T) values in the amygdala, hippocampus, insula, and frontal cortex. Pretreatment with the sigma(1) receptor agonist SA4503 (0.5 mg/kg) significantly reduced radioligand uptake in the monkey brain (>95%), indicating high binding specificity of [F-18]FBFP in vivo. Compared with (S)-[F-18]fluspidine, [F-18]FBFP possessed higher regional nondisplaceable binding potential (BPND) values across the brain regions. These findings demonstrate that [F-18]FBFP is a highly promising PET radioligand for imaging and quantification of sigma(1) receptors in humans.
What problem does this paper attempt to address?